Korean Journal of Clinical Laboratory Science (대한임상검사과학회지)

Korean Society for Clinical Laboratory Science (대한임상검사과학회)
권호 표지
DOI QR코드

DOI QR Code

The Interaction of High Sensitivity C-Reactive Protein and Uric Acid on Obesity in Koreans: Based on the Seventh Korea National Health and Nutrition Examination Survey (KNHANES VII, 2016~2018)

대한민국에서 비만에 대한 고감도 C-반응성 단백과 요산의 상호작용: 제7기 국민건강영양조사를 이용해서(KNHANES VII, 2016~2018)

  • Pyo, Sang Shin (Department of Biomedical Laboratory Science, Jungwon University)
  • Received : 2021.11.10
  • Accepted : 2021.12.03
  • Published : 2021.12.31
Download PDF
⟨ Previous Next ⟩

Abstract

We used data from the 7th Korea National Health and Nutrition Examination Survey (KNHANES) (2016~2018) to investigate an association between high sensitivity C-reactive protein (hsCRP) and uric acid in the obese. Obesity was defined as a body mass index (BMI) of 25 kg/m2 or more, severe obesity as a BMI of 30 kg/m2 or more, and morbid obesity as a BMI of 35 kg/m2 or more. In the complex samples multiple logistic regression, despite adjustment by adding major risk factors, the odds ratio (OR) for obesity was higher in the group with high levels of both, hsCRP and uric acid than the reference group at all stages (obesity, OR 1.89, P<0.001 vs. severe obesity, OR 5.04, P<0.001 vs. morbid obesity, OR 8.20, P<0.001). The association between hsCRP and uric acid in obese patients increased from 1.89 to 8.20 as the obesity level increased, suggesting that participants with increased BMI were significantly affected by hsCRP and uric acid. Moreover, the interaction between hsCRP and uric acid was statistically significant even in the model corrected for major confounding factors (P for interaction=0.009).

제7기 국민건강영양조사 자료(2016~2018)를 이용해서 고감도 C반응성 단백(hsCRP)과 요산의 비만에 대한 위험도와 상호 작용이 있는지 알아보고자 하였다. 비만은 체질량지수(BMI)가 25 kg/m2 이상으로, 중증 비만은 BMI가 30 kg/m2 이상으로, 병적 비만은 BMI가 35 kg/m2 이상으로 정의하였다. 복합표본 다중 로지스틱 회귀분석에서 주요한 위험인자를 추가하여 보정하였음에도 불구하고 고농도의 hsCRP와 고농도의 요산이 동시에 존재하는 그룹은 기준 그룹보다 비만의 오즈비(odds ratio, OR)가 모든 단계에서 높았다(비만, OR 1.89, P<0.001 vs. 심한 비만, OR 5.04, P<0.001 vs. 병적인 비만, OR 8.20, P<0.001). 비만의 단계가 높아질수록 비만에 대한 hsCRP와 요산의 오즈비가 1.89에서 8.20으로 높아졌다, 이는 BMI가 증가된 참가자일수록 hsCRP와 요산의 관련성이 크다는 것을 암시한다. 더욱이, 복합표본 일반선형분석에서 주요한 교란 요인을 보정한 후 비만에 대한 hsCRP와 요산 사이의 상호 작용이 분석되었다(P for interaction=0.009).

Keywords

References

  1. Tchkonia T, Thomou T, Zhu Y, Karagiannides I, Pothoulakis C, Jensen Michael D, et al. Mechanisms and metabolic implications of regional differences among fat depots. Cell Metabolism. 2013;17:644-656. https://doi.org/10.1016/j.cmet.2013.03.008
  2. Kim BY, Kang SM, Kang JH, Kang SY, Kim KK, Kim KB, et al. 2020 Korean society for the study of obesity guidelines for the management of obesity in Korea. JOMES. 2021;30:81-92. https://doi.org/10.7570/jomes21022
  3. Williams EP, Mesidor M, Winters K, Dubbert PM, Wyatt SB. Overweight and obesity: Prevalence, consequences, and causes of a growing public health problem. Curr Obes Rep. 2015;4:363-370. https://doi.org/10.1007/s13679-015-0169-4
  4. McLaughlin T, Abbasi F, Lamendola C, Liang L, Reaven G, Schaaf P, et al. Differentiation between obesity and insulin resistance in the association with c-reactive protein. Circulation. 2002;106:2908-2912. https://doi.org/10.1161/01.cir.0000041046.32962.86
  5. Dayal D, Jain H, Attri SV, Bharti B, Bhalla AK. Relationship of high sensitivity c-reactive protein levels to anthropometric and other metabolic parameters in indian children with simple overweight and obesity. J Clin Diagn Res. 2014;8:PC05-PC08. https://doi.org/10.7860/JCDR/2014/8191.4685
  6. Pepys MB, Hirschfield GM. C-reactive protein: A critical update. J Clin Invest. 2003;111:1805-1812. https://doi.org/10.1172/JCI18921
  7. Agnoletti D, Cicero AFG, Borghi C. The impact of uric acid and hyperuricemia on cardiovascular and renal systems. Cardiol Clin. 2021;39:365-376. https://doi.org/10.1016/j.ccl.2021.04.009
  8. Johnson RJ. Why focus on uric acid? Curr Med Res Opin. 2015;31:3-7. https://doi.org/10.1185/03007995.2015.1087979
  9. Oyama C, Takahashi T, Oyamada M, Oyamada T, Ohno T, Miyashita M, et al. Serum uric acid as an obesity-related indicator in early adolescence. Tohoku J Exp Med. 2006;209:257-262. https://doi.org/10.1620/tjem.209.257
  10. Ali N, Perveen R, Rahman S, Mahmood S, Rahman S, Islam S, et al. Prevalence of hyperuricemia and the relationship between serum uric acid and obesity: a study on bangladeshi adults. PLoS One. 2018;13:e0206850. https://doi.org/10.1371/journal.pone.0206850
  11. Oh K, Kim Y, Kweon S, Kim S, Yun S, Park S, et al. Korea National Health and Nutrition Examination Survey, 20th anniversary: accomplishments and future directions. Epidemiol Health. 2021;43:e2021025. https://doi.org/10.4178/epih.e2021025
  12. Chen C, Lu JM, Yao Q. Hyperuricemia-related diseases and xanthine oxidoreductase (xor) inhibitors: an overview. Med Sci Monit. 2016;22:2501-2512. https://doi.org/10.12659/msm.899852
  13. Pearson TA, Mensah GA, Alexander RW, Anderson JL, Cannon RO, Criqui M, et al. Markers of inflammation and cardiovascular disease. Circulation. 2003;107:499-511. https://doi.org/10.1161/01.CIR.0000052939.59093.45
  14. Seo MH, Lee WY, Kim SS, Kang JH, Kang JH, Kim KK, et al. 2018 Korean society for the study of obesity guideline for the management of obesity in korea. J Obes Metab Syndr. 2019;28:40-45. https://doi.org/10.7570/jomes.2019.28.1.40
  15. Chun MY. Validity and reliability of Korean version of international physical activity questionnaire short form in the elderly. Korean J Fam Med. 2012;33:144-151. https://doi.org/10.4082/kjfm.2012.33.3.144
  16. Garrett SL, Pina-Thomas DM, Peterson KA, Benton MJ. Tracking physical activity in baccalaureate nursing students in the united states prior to graduation: a longitudinal study. Nurse Educ Today. 2019;80:28-33. https://doi.org/10.1016/j.nedt.2019.05.038
  17. Huang PL. A comprehensive definition for metabolic syndrome. Dis Model Mech. 2009;2:231-237. https://doi.org/10.1242/dmm.001180
  18. Shirasawa T, Ochiai H, Yoshimoto T, Nagahama S, Watanabe A, Yoshida R, et al. Cross-sectional study of associations between normal body weight with central obesity and hyperuricemia in japan. BMC Endocrine Disorders. 2020;20:2. https://doi.org/10.1186/s12902-019-0481-1
  19. Johnson RJ, Nakagawa T, Sanchez-Lozada LG, Shafiu M, Sundaram S, Le M, et al. Sugar, uric acid, and the etiology of diabetes and obesity. Diabetes. 2013;62:3307-3315. https://doi.org/10.2337/db12-1814
  20. Zeng J, Lawrence WR, Yang J, Tian J, Li C, Lian W, et al. Association between serum uric acid and obesity in chinese adults: a 9-year longitudinal data analysis. BMJ Open. 2021;11:041919. https://doi.org/10.1136/bmjopen-2020-041919
  21. Grant RW, Dixit VD. Adipose tissue as an immunological organ. Obesity (Silver Spring). 2015;23:512-518. https://doi.org/10.1002/oby.21003
  22. Goossens GH. The role of adipose tissue dysfunction in the pathogenesis of obesity-related insulin resistance. Physiol Behav. 2008;94:206-218. https://doi.org/10.1016/j.physbeh.2007.10.010
  23. Tsushima Y, Nishizawa H, Tochino Y, Nakatsuji H, Sekimoto R, Nagao H, et al. Uric acid secretion from adipose tissue and its increase in obesity. J Biol Chem. 2013;288:27138-27149. https://doi.org/10.1074/jbc.M113.485094
  24. Sah SK, Khatiwada S, Pandey S, Kc R, Das BK, Baral N, et al. Association of high-sensitivity c-reactive protein and uric acid with the metabolic syndrome components. Springerplus. 2016;5:269. https://doi.org/10.1186/s40064-016-1933-y
  25. Keenan T, Blaha MJ, Nasir K, Silverman MG, Tota-Maharaj R, Carvalho JA, et al. Relation of uric acid to serum levels of high-sensitivity c-reactive protein, triglycerides, and high-density lipoprotein cholesterol and to hepatic steatosis. Am J Cardiol. 2012;110:1787-1792. https://doi.org/10.1016/j.amjcard.2012.08.012
  26. Leon-Pedroza JI, Escobedo G, Gonzalez-Chavez A. Relationship of hyperuricemia with low density lipoprotein, liver function tests and markers of systemic inflammation in patients with morbid obesity. Gac Med Mex. 2017;153:S42-S50. https://doi.org/10.24875/gmm.17000006
  27. Kawamoto R, Tabara Y, Kohara K, Miki T, Kusunoki T, Takayama S, et al. Usefulness of combining serum uric acid and high-sensitivity C-reactive protein for risk stratification of patients with metabolic syndrome in community-dwelling women. Endocrine. 2013;44:132-139. https://doi.org/10.1007/s12020-013-9912-3
  28. Alberts A, Klingberg A, Wessig AK, Combes C, Witte T, Brand K, et al. C-reactive protein (CRP) recognizes uric acid crystals and recruits proteases C1 and MASP1. Sci Rep. 2020;10:6391. https://doi.org/10.1038/s41598-020-63318-8
  29. Lu J, Bai Z, Chen Y, Li Y, Tang M, Wang N, et al. Effects of bariatric surgery on serum uric acid in people with obesity with or without hyperuricaemia and gout: a retrospective analysis. Rheumatology (Oxford). 2021;60:3628-3634. https://doi.org/10.1093/rheumatology/keaa822
  30. Lautenbach A, Stoll F, Mann O, Busch P, Huber TB, Kielstein H, et al. Long-term improvement of chronic low-grade inflammation after bariatric surgery. Obesity Surgery. 2021;31:2913-2920. https://doi.org/10.1007/s11695-021-05315-y